The Scientific Research Team at Mythic Therapeutics is dedicated to advancing the company's FateControl technology, focusing on the development and optimization of Antibody Drug Conjugates (ADCs) that specifically target and eliminate cancer cells while sparing healthy tissues. This team collaborates across disciplines, leveraging expertise in biology, antibody engineering, and protein sciences to drive innovative research and facilitate the translation of scientific discoveries into effective cancer therapies.
View all